ILYANG PHARMACEUTICAL CO.,LTD Logo

ILYANG PHARMACEUTICAL CO.,LTD

Develops & manufactures drugs, vaccines & supplements for oncology & gastroenterology needs.

007570 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
경기도 용인시 기흥구 하갈로 110, 용인시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Founded in 1946, Ilyang Pharmaceutical is a research-driven company focused on the development and manufacturing of pharmaceutical products. The company's portfolio includes a wide range of prescription drugs, over-the-counter medications, vaccines, and health supplements. It has developed key products in therapeutic areas such as oncology, gastroenterology, and circulatory system disorders. Notable developments include Supect®, a new chemical entity for the treatment of leukemia, and Noltec®, an anti-ulcer agent. Ilyang emphasizes high-quality production through advanced manufacturing facilities and a commitment to innovation in addressing global health needs.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-11 00:00
Legal Proceedings Report
회계처리기준위반에따른검찰고발등조치
Korean 7.0 KB
2025-09-11 00:00
Legal Proceedings Report
기타시장안내 (상장적격성 실질심사 사유 발생)
Korean 4.9 KB
2025-09-11 00:00
Legal Proceedings Report
[기재정정]기타시장안내 (상장적격성 실질심사 사유 발생)
Korean 8.2 KB
2025-09-10 00:00
Regulatory News Service
매매거래정지및정지해제(풍문등조회공시)
Korean 5.1 KB
2025-09-10 00:00
Legal Proceedings Report
조회공시요구(풍문또는보도)
Korean 3.5 KB
2025-09-05 00:00
Regulatory News Service
[기재정정]단일판매ㆍ공급계약체결
Korean 13.1 KB
2025-08-18 00:00
Transaction in Own Shares
주요사항보고서(자기주식취득신탁계약해지결정)
Korean 27.7 KB
2025-08-18 00:00
Transaction in Own Shares
신탁계약해지결과보고서
Korean 19.8 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.6 MB
2025-06-02 00:00
Regulatory News Service
단일판매ㆍ공급계약체결
Korean 7.5 KB
2025-05-21 00:00
Major Shareholding Notification
신탁계약에의한취득상황보고서
Korean 55.7 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.5 MB
2025-05-15 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB
2025-05-13 00:00
Major Shareholding Notification
최대주주등소유주식변동신고서
Korean 32.6 KB
2025-04-30 00:00
Major Shareholding Notification
최대주주등소유주식변동신고서
Korean 37.6 KB

Automate Your Workflow. Get a real-time feed of all ILYANG PHARMACEUTICAL CO.,LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for ILYANG PHARMACEUTICAL CO.,LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
2cureX AB Logo
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden 2CUREX
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
4SC AG Logo
Developing small-molecule epigenetic drugs for high-need cancer indications.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden ABERA
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
Abliva Logo
Develops clinical-stage medicines for rare primary mitochondrial diseases to restore cell function.
Sweden ABLI
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
Access Bio, Inc. Logo
Develops and manufactures rapid diagnostic tests for infectious diseases for global health.
United States of America 950130
Active Biotech Logo
Develops immunology-based drugs for cancer and inflammatory diseases with high unmet medical need.
Sweden ACTI

Talk to a Data Expert

Have a question? We'll get back to you promptly.